MetLife Investment Management’s Synovus SNV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-418,832
| Closed | -$21M | – | 2835 |
|
|
2025
Q4 | $21M | Sell |
418,832
-3,287
| -0.8% | -$158K | 0.1% | 154 |
|
|
2025
Q3 | $20.7M | Sell |
422,119
-37,912
| -8% | -$1.94M | 0.1% | 157 |
|
|
2025
Q2 | $23.8M | Buy |
460,031
+65,563
| +17% | +$3.01M | 0.14% | 115 |
|
|
2025
Q1 | $18.4M | Buy |
394,468
+314,576
| +394% | +$16.2M | 0.1% | 173 |
|
|
2024
Q4 | $4.09M | Buy |
79,892
+5,487
| +7% | +$284K | 0.02% | 678 |
|
|
2024
Q3 | $3.31M | Sell |
74,405
-2,699
| -4% | -$118K | 0.02% | 766 |
|
|
2024
Q2 | $3.1M | Sell |
77,104
-3,206
| -4% | -$122K | 0.02% | 761 |
|
|
2024
Q1 | $3.22M | Sell |
80,310
-2,118
| -3% | -$79.6K | 0.02% | 743 |
|
|
2023
Q4 | $3.1M | Sell |
82,428
-1,307
| -2% | -$40K | 0.02% | 749 |
|
|
2023
Q3 | $2.33M | Sell |
83,735
-3,800
| -4% | -$119K | 0.02% | 834 |
|
|
2023
Q2 | $2.65M | Sell |
87,535
-1,646
| -2% | -$48.1K | 0.02% | 810 |
|
|
2023
Q1 | $2.75M | Sell |
89,181
-2,370
| -3% | -$90.2K | 0.02% | 783 |
|
|
2022
Q4 | $3.44M | Sell |
91,551
-1,778
| -2% | -$70.6K | 0.03% | 655 |
|
|
2022
Q3 | $3.5M | Sell |
93,329
-1,158
| -1% | -$45.9K | 0.03% | 598 |
|
|
2022
Q2 | $3.41M | Buy |
94,487
+222
| +0.2% | +$9.18K | 0.03% | 653 |
|
|
2022
Q1 | $4.62M | Buy |
94,265
+23,749
| +34% | +$1.2M | 0.03% | 588 |
|
|
2021
Q4 | $3.38M | Buy |
70,516
+162
| +0.2% | +$7.67K | 0.03% | 619 |
|
|
2021
Q3 | $3.09M | Sell |
70,354
-3,897
| -5% | -$165K | 0.03% | 623 |
|
|
2021
Q2 | $3.26M | Sell |
74,251
-2,529
| -3% | -$119K | 0.03% | 620 |
|
|
2021
Q1 | $3.51M | Sell |
76,780
-4,101
| -5% | -$172K | 0.03% | 584 |
|
|
2020
Q4 | $2.62M | Sell |
80,881
-3,461
| -4% | -$100K | 0.02% | 700 |
|
|
2020
Q3 | $1.79M | Sell |
84,342
-3,124
| -4% | -$65.1K | 0.02% | 768 |
|
|
2020
Q2 | $1.8M | Buy |
87,466
+3,348
| +4% | +$64.8K | 0.02% | 762 |
|
|
2020
Q1 | $1.48M | Hold |
84,118
| – | – | 0.02% | 735 |
|
|
2019
Q4 | $3.3M | Sell |
84,118
-5,638
| -6% | -$207K | 0.03% | 583 |
|
|
2019
Q3 | $3.21M | Sell |
89,756
-3,557
| -4% | -$128K | 0.04% | 561 |
|
|
2019
Q2 | $3.27M | Sell |
93,313
-3,701
| -4% | -$129K | 0.03% | 566 |
|
|
2019
Q1 | $3.33M | Sell |
97,014
-4,004
| -4% | -$147K | 0.04% | 556 |
|
|
2018
Q4 | $3.23M | Buy |
101,018
+29,176
| +41% | +$1.1M | 0.04% | 503 |
|
|
2018
Q3 | $3.29M | Sell |
71,842
-2,723
| -4% | -$137K | 0.03% | 611 |
|
|
2018
Q2 | $3.94M | Buy |
74,565
+502
| +0.7% | +$26.7K | 0.05% | 431 |
|
|
2018
Q1 | $3.7M | Sell |
74,063
-1,588
| -2% | -$80K | 0.04% | 482 |
|
|
2017
Q4 | $3.63M | Buy |
+75,651
| New | +$3.58M | 0.04% | 523 |
|
Other funds holding SNV
MetLife Investment Management's SNV Position: Q1 2026 in Review
MetLife Investment Management sold out of Synovus (SNV) in Q1 2026, closing a stake of 418,832 shares — an estimated $21M sold.
MetLife Investment Management first reported a position in SNV in Q4 2017 and held it in 33 quarters. The position peaked at $23.8M in Q2 2025. 1 fund tracked by Wall St. Rank holds SNV as of Q1 2026.
- MetLife Investment Management reported no remaining Synovus position as of Q1 2026 after selling out during the quarter.
- MetLife Investment Management sold 418,832 Synovus shares in Q1 2026, an estimated $21M.
- MetLife Investment Management first reported a position in Synovus in Q4 2017 and held it in 33 quarters.
- MetLife Investment Management's Synovus position peaked at $23.8M in Q2 2025.
- 1 fund tracked by Wall St. Rank held Synovus as of Q1 2026.
Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.